Heart Drug

Titel Veröffentlichungsdatum Sprache Zitate
Heart Failure in the Elderly: Characteristics of a Swedish Primary Health Care Population2002/01/01English25
Value of N-Terminal proBNP in the Diagnosis of Left Ventricular Systolic Dysfunction in Primary Care Patients Referred for Echocardiography2003/01/01English22
Regulation of Hemostasis by the Sympathetic Nervous System: Any Contribution to Coronary Artery Disease?2004/01/01English22
Influenza and Pneumococcal Vaccinations Fail to Prevent Myocardial Infarction2004/01/01English16
Intervention with Clarithromycin in Patients with Stable Coronary Heart Disease2001/01/01English16
Hyperglycemia after Acute Ischemic Stroke: Prediction, Significance and Immediate Control with Insulin-Potassium-Saline-Magnesium Infusions2005/01/01English14
Drug-Eluting Stents2003/01/01English10
Standardization of Central Off-Line Quantitative Image Analysis: Implications from Experiences with Quantitative Coronary Angiography2001/01/01English10
The Frederiksberg Heart Failure Study: Rationale, Design and Methodology, with Special Emphasis on the Sampling Procedure for the Study Population and Its Comparison to the Background Population2002/01/01English10
Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial Infarction2001/01/01English10
Regional Inequality in the Risk of Acute Myocardial Infarction in Finland: A Case Study of 35- to 74-Year-Old Men2002/01/01English8
The Danish Multicenter Randomized Study on Atrial Inhibited versus Dual-Chamber Pacing in Sick Sinus Syndrome (The DANPACE Study)2001/01/01English8
Safety of Bone Marrow Stem Cell Mobilization Induced by Granulocyte-Colony Stimulating Factor: 30 Days’ Blinded Clinical Results from the Stem Cells in Myocardial Infarction (STEMMI) Trial2005/01/01English8
Nicorandil – Review of Pharmacological Properties and Clinical Applications2005/01/01English8
Early Drug Therapy and In-Hospital Mortality following Acute Myocardial Infarction2003/01/01English7
Evidence for the Benefits of the Low-Molecular-Weight Heparin Dalteparin in ‘High-Risk’ Patients with Acute Coronary Syndromes2004/01/01English7
Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial Infarction2001/01/01English7
Amiodarone: The Last and/or Best Hope for Pharmacological Control of Cardiac Arrhythmias?2001/01/01English7
Prognostic Comparison of the Minute Ventilation/Carbon Dioxide Production Ratio and Slope in Patients with Heart Failure2004/01/01English7
Effect of N-Acetylcysteine on Serum Creatinine Concentration in Patients with Chronic Renal Insufficiency Who Are Undergoing Coronary Angiography2004/01/01English7
Trial of Invasive versus Medical Therapy in the Elderly (TIME)2001/01/01English6
Incidence of and Predicting Factors for Torsades de Pointes during Intravenous Administration of Amiodarone2001/01/01English6
Blinded End Point Adjudication in the ‘Danish Multicenter Randomized Study on Fibrinolytic Therapy versus Acute Coronary Angioplasty in Acute Myocardial Infarction’ (DANAMI-2 Trial)2003/01/01English6
Variability in Cytochrome P450-Mediated Metabolism of Cardiovascular Drugs: Clinical Implications and Practical Attempts to Avoid Potential Problems2004/01/01English6
Beyond Traditional Risk Factors: Homocysteine and Atherosclerosis2001/01/01English5
Prior Aspirin Therapy, Subsequent Stroke Severity and Mortality and Relationship with Cardiovascular Risk Factors in Patients Admitted to Hospital with Acute Stroke2002/01/01English5
Thromboembolic Prophylaxis with Fondaparinux in Major Orthopaedic Surgery: Outcomes and Costs2005/01/01English5
Sufficient Weight Reduction Decreases Cardiovascular Complications in Diabetic Patients with the Metabolic Syndrome2005/01/01English5
N-Terminal ProBNP: Marker of Systolic Dysfunction or Nonspecific Indicator of Cardiac Disease?2003/01/01English4
Platelets and Thrombolysis: Cooperation or Contrariety?2001/01/01English4